Anthem Blue Cross (HMO, PPO, EPO)
Blincyto (blinatumomab)
Drugs for Cancer : Drugs for Cancer
  • Prior Authorization: Acute Lymphoblastic Leukemia:
    Documented Diagnosis: Yes
    Medical Test Required: Yes
    Duration: 1 year(s)

  • Available only through Specialty Pharmacy;
    For FAX form click HERE
    Our electronic prior authorization (ePA) process is the preferred method for submitting pharmacy prior authorization requests. Creating an account is free, easy and helps patients get their medications sooner. You can complete the process through your current electronic health record/electronic medical record (EHR/EMR) system or by using one of these ePA sites:
     Log in to Surescripts
     Log in to CoverMyMeds; For details on drug coverage click  HERE;
  • Acute Lymphoblastic Leukemia:
    Duration: 1 year(s)
    Documented Diagnosis: Yes
    Medical Test Required: Yes
    Specialty Pharmacy Provider(s): Accredo Health Group, Inc.
    Reauthorization Required: No
    Duration of Reauthorization: N/A
    Drug Policy Based On: Payer Specific
    Diagnosis Types: 2 of as a single agent;CD19+ B-cell precursor ALL;First or second complete remission B-cell precursor type. MRD is greater than or equal to 0.1%;R/R CD19+ B-cell precursor ALL
    ECOG Score Requirement Included in Policy: N/A
    Contraindications: Active CNS malignancy involvement
    Specialty Pharmacy is Required: Y

  • PA Applies